Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Bordas

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 11, 2006
A prospective evaluation of the cost of psoriasis in Spain (EPIDERMA project: phase II)J M Carrascosa, R Pujol, E Daudén, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 9, 2015
Adherence of self-administered subcutaneous methotrexate in patients with chronic plaque-type psoriasisD Vidal, M Salleras, J Romaní, et al.
Actas Dermo-Sifiliograficas|May 19, 2009
[Reactions to infliximab infusions in dermatologic patients: consensus statement and treatment protocol. Working Group of the Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología ]Lluís Puig Sanz, E Sáez, M J Lozano, et al.
The British Journal of Dermatology|September 19, 2012
Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical settingR Navarro, E Vilarrasa, P Herranz, et al.
Actas Dermo-Sifiliograficas|May 26, 2009
[Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology]L Puig, X Bordas, J M Carrascosa, et al.
Actas Dermo-Sifiliograficas|June 30, 2009
[Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents]L Puig, J M Carrascosa, E Daudén, et al.
Actas Dermo-Sifiliograficas|May 22, 2009
[Update of the topical treatment of psoriasis]J M Carrascosa, F Vanaclocha, L Borrego, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 18, 2014
Use of biological treatments in patients with hidradenitis suppurativaG Martin-Ezquerra, E Masferrer, M Masferrer-Niubò, et al.
Actas Dermo-Sifiliograficas|November 29, 2015
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert RecommendationsJ M Carrascosa, P de la Cueva, M Ara, et al.
Actas Dermo-Sifiliograficas|March 13, 2010
[Adverse reactions during biological therapy for psoriasis: results of a survey of the Spanish Psoriasis Group]M Sánchez-Regaña, E Dilmé, Ll Puig, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 11, 2006
A prospective evaluation of the cost of psoriasis in Spain (EPIDERMA project: phase II)J M Carrascosa, R Pujol, E Daudén, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 9, 2015
Adherence of self-administered subcutaneous methotrexate in patients with chronic plaque-type psoriasisD Vidal, M Salleras, J Romaní, et al.
Actas Dermo-Sifiliograficas|May 19, 2009
[Reactions to infliximab infusions in dermatologic patients: consensus statement and treatment protocol. Working Group of the Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología ]Lluís Puig Sanz, E Sáez, M J Lozano, et al.
The British Journal of Dermatology|September 19, 2012
Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical settingR Navarro, E Vilarrasa, P Herranz, et al.
Actas Dermo-Sifiliograficas|May 26, 2009
[Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology]L Puig, X Bordas, J M Carrascosa, et al.
Actas Dermo-Sifiliograficas|June 30, 2009
[Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents]L Puig, J M Carrascosa, E Daudén, et al.
Actas Dermo-Sifiliograficas|May 22, 2009
[Update of the topical treatment of psoriasis]J M Carrascosa, F Vanaclocha, L Borrego, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 18, 2014
Use of biological treatments in patients with hidradenitis suppurativaG Martin-Ezquerra, E Masferrer, M Masferrer-Niubò, et al.
Actas Dermo-Sifiliograficas|November 29, 2015
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert RecommendationsJ M Carrascosa, P de la Cueva, M Ara, et al.
Actas Dermo-Sifiliograficas|March 13, 2010
[Adverse reactions during biological therapy for psoriasis: results of a survey of the Spanish Psoriasis Group]M Sánchez-Regaña, E Dilmé, Ll Puig, et al.
Pageof 3